The massive pharmaceuticals distributor said it is offering employees severance. It plans to begin layoffs on March 3.

McKesson (MCK) ended the recent trading session at $579.29, demonstrating a +0.45% swing from the preceding day's closing price. The stock outperformed the S&P 500, which registered a daily loss of 0.

McKesson (MCK) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

In a report released today, Allen Lutz from Bank of America Securities maintained a Buy rating on McKesson (MCK – Research Report). The ...

McKesson , which belongs to the Zacks Medical - Dental Supplies industry, posted revenues of $93.65 billion for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 4.66%.

Health-care solution providers are bracing for the pending arrival of a bigger player in their market after medical supply behemoth McKesson splits off its technology solutions business.

McKesson Corporation MCK witnessed strong ... along with other healthcare-related products, on a global basis. The second segment offers enterprise-wide clinical, patient care, financial, supply ...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Mizuho Securities analyst Ann Hynes maintained a Hold rating on McKesson (MCK – Research Report) on December 3. The company’s shares opened ...